Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.
DSS, Inc. (NYSE American: DSS) generates news across a wide range of sectors, reflecting its role as a multinational company with diversified business lines in packaging, biohealth innovation, financial services, alternative trading, and real estate. The company’s press releases and regulatory disclosures highlight strategic transactions, capital markets developments, operational milestones, and portfolio optimization efforts.
News about DSS often covers corporate strategy and portfolio management, including spin-offs, asset sales, and transactions involving key subsidiaries. Examples include the sale of the Celios air purification asset to Impact BioMedical Inc., as well as a definitive merger agreement under which Impact BioMedical will be acquired through a reverse merger with Dr. Ashleys Limited, resulting in a new public company. These items illustrate DSS’s stated approach of unlocking value by advancing subsidiaries toward independent public listings and other exit opportunities.
Investors and followers of DSS can also expect updates on financial performance and corporate actions. The company reports on revenue trends, cash flow improvements, debt reduction, and asset monetization, such as the sale of a real estate facility and growth in rental income. Leadership communications, including letters to shareholders and announcements of executive appointments, provide additional context on strategic priorities, cost reduction initiatives, and the focus on core growth verticals.
Because DSS has subsidiaries in securities and investment management, its news flow includes developments at entities like Sentinel Brokers Company, Inc. and AmericaFirst Funds. These updates may involve regulatory approvals, such as FINRA authorization for underwriting activities, changes to mutual fund boards, and expansion of capital markets capabilities. For a comprehensive view of DSS-related developments, readers can use this news page to follow corporate strategy, subsidiary activity, and key financial and regulatory events over time.
DSS, a multinational company, announced its participation in the Emerging Growth Conference on December 8, 2021, at 2:30 p.m. ET. The event allows for real-time interaction between investors and the company's management team, including CEO Frank D. Heuszel, COO Jason Grady, and CFO Todd Macko. Attendees can ask questions following the presentation. Registration is required in advance, with a recorded version available later for those unable to attend live. DSS operates in sectors such as blockchain security, healthcare, and renewable energy.
On November 30, 2021, DSS announced the launch of DSS AmericaFirst Quantitative Funds, a suite of mutual funds managed by DSS Wealth Management. The funds include four offerings: Income Trends Fund, Defensive Growth Fund, Risk-On Risk-Off Fund, and Large Cap Buyback Fund, each aiming to outperform benchmark indices using a quantitative approach. CEO Frank D. Heuszel emphasized the growth potential and innovative strategies behind the funds. DSS Wealth Management serves as the registered investment advisor to the funds, earning fees based on average daily net assets.
DSS, Inc. (NYSE American: DSS) announced that its subsidiary, American Medical REIT Inc. (AMRE), has acquired three hospitals in Texas and Pennsylvania for $62 million. Currently under an 18-year lease with LifeCare Hospitals, these facilities offer a combined capacity of 195 beds and span approximately 320,000 square feet. The acquisition aims to expand AMRE's portfolio and create sustainable dividends for shareholders. DSS CEO Frank D. Heuszel emphasized the acquisition's strategic importance in enhancing their real estate operations in the resilient medical sector.
DSS, Inc. (NYSE American: DSS) announced that COO Jason Grady will be featured on The RedChip Money Report on Bloomberg TV on Oct. 30 at 7 p.m. ET. In the interview, Grady will highlight DSS's diverse subsidiaries and its strategy for scalable, recurring revenue aimed at achieving positive EBITDA. The company operates in several sectors, including blockchain security and renewable energy, and focuses on unlocking shareholder value through strategic IPOs of its subsidiaries. DSS's emphasis on building a robust portfolio positions it for growth in high-demand markets.
DSS, Inc. (NYSE American: DSS) announced the launch of Liquid Value Asset Management Limited (LVAM), a Hong Kong-based investment management firm, primarily owned by its subsidiary DSS Financial Management, Inc. (DFMI). DFMI has provided a $1 million working capital loan to expedite LVAM's operations, which will commence with $9 million in proprietary trading. LVAM aims for attractive risk-adjusted returns using advanced algorithmic trading strategies. CEO Wilson Lee and his team will manage the firm, which targets scalable trading programs and rapid portfolio liquidation capabilities.
DSS, Inc. (NYSE American: DSS) announced its stock trading under a new CUSIP number effective October 1, 2021, following its name change. The company has undergone significant transformation in the past two years, focusing on high-growth markets including digital assets, healthcare, and renewable energy. COO Jason Grady emphasized this milestone as part of DSS's long-term strategy to enhance shareholder value. DSS operates a diversified business model and plans to unlock shareholder value via IPO spin-offs from its subsidiaries.
Summary not available.
Document Security Systems (DSS) has signed a $40 million subscription agreement with American Pacific Bancorp (APB) to acquire 6,666,700 shares at $6.00 each, making DSS a majority owner of APB. This investment aims to bolster APB's capacity for diversified lending, including mortgages and medical real estate financing. DSS anticipates quick deployment of this capital to generate interest before the end of 2021, highlighting a strong validation of APB's business model.
Document Security Systems (DSS) announced a significant investment of $15 million from Alset EHome International, which will see the issuance of 12,155,591 shares at $1.234 per share. This strategic partnership indicates strong confidence from Alset in DSS and aims to enhance growth opportunities for both entities. DSS operates across multiple sectors, including blockchain security and healthcare, and has a unique business model that allows shareholders to benefit from its subsidiary IPOs. CEO Frank D. Heuszel emphasized the mutual growth potential between the companies.
Impact BioMedical, a subsidiary of DSS, and GRDG Sciences have successfully synthesized their first Quantum-based compound aimed at enhancing immune response. This achievement follows over a year of research initiated in Summer 2020. The compound, designed to improve therapeutic efficacy and combat a projected patent cliff in the pharmaceutical industry, will undergo testing at a prominent university. The development of this compound, inspired by quantum mechanics, could potentially lead to significant medical breakthroughs and a new class of medicines.